Better Buy: Abbott Laboratories vs. Intuitive Surgical
Investors looking for stocks that can go up want to turn their heads toward the medical technology industry. Demand for devices that enable minimally invasive surgical procedures and remote monitoring of patients with chronic conditions is on the rise.
With roughly 10,000 baby boomers reaching the age of Medicare eligibility every day, companies like Abbott Laboratories (NYSE: ABT) and Intuitive Surgical (NASDAQ: ISRG) can rely on a steadily growing customer base. Both of these businesses have their best days ahead, but which is best for your investment goals?
If you want a stock for uncertain times, Abbott Laboratories could set your mind at ease. This constantly shifting collection of healthcare businesses hasn't missed a quarterly dividend payment in nearly a century. Plus, it's increased its payout for 51 consecutive years. At recent prices, the stock offers a 2.1% yield.
Source Fool.com
Abbott Laboratories Aktie
Positive Einschätzungen für Abbott Laboratories überwiegen: Mehrere Buy-, keine Sell-Einschätzungen.
Für Abbott Laboratories sieht die Community ein leicht positives Kursziel von 116 €, verglichen mit dem aktuellen Kurs von 101.98 €.
